Clinical Trial Update: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) [Phase 1, Phase 2]

View source ↗

Summary

A pharmacokinetic study evaluating three Tolvaptan dose levels in patients with SIADH was completed (Phase 1/2) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-16